SCHEDULE 13G/A: T. Rowe Price Associates Reduces Stake in ATMUS Filtration Technologies to 2.5%

T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, reporting a reduction in its beneficial ownership stake in ATMUS FILTRATION TECHNOLOGIE to 2.5% as of March 31, 2025.

Summary

• T. Rowe Price Associates, Inc. reported beneficial ownership of 2,123,377 shares of ATMUS FILTRATION TECHNOLOGIE common stock.
• This represents 2.5% of the company's common stock, a decrease from a previous holding that was likely above the 5% threshold.
• The filing date for this amendment is May 14, 2025, with the event date being March 31, 2025.
• T. Rowe Price Associates, Inc. holds sole voting power over 2,119,737 shares and sole dispositive power over 2,123,377 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 3

Explanation: The filing indicates a reduction in T. Rowe Price Associates, Inc.'s beneficial ownership to 2.5%, suggesting a decrease from a prior holding that was likely above 5%. This reduction in institutional stake is generally perceived as a negative signal by the market, indicating potentially diminished confidence from a major institutional investor.

Negatives

• The reduction of T. Rowe Price Associates, Inc.'s beneficial ownership in ATMUS FILTRATION TECHNOLOGIE to 2.5% implies a decrease from a previous holding that was likely above the 5% threshold, which can be perceived as a negative signal regarding institutional confidence.

Future Outlook

The document does not provide any forward-looking statements or guidance from ATMUS FILTRATION TECHNOLOGIE.

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."
• "T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied."

Industry Context

This filing reflects a change in institutional investor holdings for ATMUS FILTRATION TECHNOLOGIE. A reduction in a significant institutional stake can influence market perception and potentially signal a shift in investor sentiment towards the company or the broader filtration technology sector.

Stakeholder Impact

• Shareholders may perceive the reduction in T. Rowe Price's stake as a negative signal, potentially leading to a decrease in share price due to concerns about institutional confidence.

Key Dates

Recommendation

Keywords

ATMUS FILTRATION TECHNOLOGIE, T. Rowe Price Associates Inc., Schedule 13G, beneficial ownership, common stock, institutional investor, ownership change